导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -22.03% | 1013/1050 |
| 近一周 | -2.21% | 497/1104 |
| 近一月 | -10.05% | 1037/1102 |
| 近一季 | -24.80% | 1044/1092 |
| 近半年 | -25.59% | 1035/1070 |
| 近一年 | -21.63% | 925/1018 |
| 近两年 | 19.14% | 784/926 |
| 近三年 | 5.00% | 625/834 |
| 成立以来 | 187.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.54% 530/1070 |
3.45% 645/1101 |
- - |
- - |
| 2025 | 36.13% 378/1065 |
2.61% 593/1014 |
-1.09% 777/1038 |
46.65% 113/1050 |
-8.54% 848/1065 |
| 2024 | 9.15% 309/1011 |
6.28% 78/960 |
-2.70% 481/983 |
14.18% 287/991 |
-7.56% 804/1011 |
| 2023 | -29.92% 805/952 |
-7.73% 836/880 |
-2.37% 329/895 |
-14.43% 759/915 |
-9.08% 817/952 |
| 2022 | -25.18% 501/867 |
-16.88% 354/773 |
18.63% 35/806 |
-17.13% 685/845 |
-8.43% 752/867 |
| 2021 | 30.94% 66/740 |
-11.09% 509/580 |
32.95% 38/659 |
9.07% 78/704 |
1.56% 374/740 |
| 2020 | 123.91% 9/554 |
-5.84% 312/419 |
36.15% 56/466 |
25.04% 19/517 |
39.68% 13/554 |
| 2019 | 50.43% 145/410 |
27.66% 509/1146 |
-4.75% 691/1228 |
3.64% 228/390 |
19.37% 17/410 |
| 2018 | - - |
- - |
-7.48% 305/990 |
-7.44% 619/1000 |
-4.88% 54/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中欧先进制造股票C VS. 东吴新产业精选股票A(580008) |